Your search returned 53 results.

Results
	1.	A randomized, double-blind, parallel-group, multicenter, placebo-controlled study of the safety and efficacy of extended-release guaifenesin/pseudoephedrine hydrochloride for symptom relief as an adjunctive therapy to antibiotic treatment of acute respiratory infections. [electronic resource] by LaForce, Craig Gentile, Deborah A Skoner, David P Producer: 20081021 In: Postgraduate medicine vol. 120 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Albuterol multidose dry powder inhaler efficacy and safety versus placebo in children with asthma. [electronic resource] by LaForce, Craig Taveras, Herminia Iverson, Harald Shore, Paul Producer: 20170316 In: Allergy and asthma proceedings vol. 38 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma. [electronic resource] by Pearlman, David S LaForce, Craig F Kaiser, Kirsten Producer: 20140127 In: Clinical therapeutics vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	24-hour bronchodilator efficacy of single doses of indacaterol in patients with persistent asthma: comparison with placebo and formoterol. [electronic resource] by LaForce, Craig Korenblat, Phillip Osborne, Pamela Dong, Fang Higgins, Mark Producer: 20091127 In: Current medical research and opinion vol. 25 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Profiling the bronchodilator effects of the novel ultra-long-acting β2-agonist indacaterol against established treatments in chronic obstructive pulmonary disease. [electronic resource] by Vogelmeier, Claus Magnussen, Helgo LaForce, Craig Owen, Roger Kramer, Benjamin Producer: 20111228 In: Therapeutic advances in respiratory disease vol. 5 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Impact of exhaled nitric oxide measurements on treatment decisions in an asthma specialty clinic. [electronic resource] by LaForce, Craig Brooks, Elizabeth Herje, Nancy Dorinsky, Paul Rickard, Kathy Producer: 20150129 In: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 113 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis. [electronic resource] by LaForce, Craig van Bavel, Julius Meltzer, Eli O Wingertzahn, Mark A Producer: 20091002 In: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 103 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	8.	Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. [electronic resource] by LaForce, Craig F Corren, Jonathan Wheeler, William J Berger, William E Producer: 20040923 In: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD. [electronic resource] by Weinstein, Cindy Staudinger, Heribert Scott, Ian Amar, Niran J LaForce, Craig Producer: 20110824 In: Respiratory medicine vol. 105 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Once-daily indacaterol 75 μg in moderate- to-severe COPD: results of a Phase IV study assessing time until patients' perceived onset of effect. [electronic resource] by Siler, Thomas M LaForce, Craig F Kianifard, Farid Williams, James Spangenthal, Selwyn Producer: 20150224 In: International journal of chronic obstructive pulmonary disease vol. 9 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	11.	MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. [electronic resource] by Meltzer, Eli O LaForce, Craig Ratner, Paul Price, David Ginsberg, David Carr, Warner Producer: 20121220 In: Allergy and asthma proceedings vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	12.	Randomised, double-blind, placebo-controlled crossover study to investigate different dosing regimens of olodaterol delivered via Respimat® in patients with moderate to severe persistent asthma. [electronic resource] by Beeh, Kai-Michael LaForce, Craig Gahlemann, Martina Wenz, Arne Toorawa, Robert Fležar, Matjaž Producer: 20160401 In: Respiratory research vol. 16 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Long-term safety of tiotropium/olodaterol Respimat [electronic resource] by LaForce, Craig Derom, Eric Bothner, Ulrich Kloer, Isabel M Trampisch, Matthias Buhl, Roland Producer: 20190116 In: International journal of chronic obstructive pulmonary disease vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Once-daily ciclesonide improves lung function and is well tolerated by patients with mild-to-moderate persistent asthma. [electronic resource] by Pearlman, David S Berger, William E Kerwin, Edward Laforce, Craig Kundu, Sudeep Banerji, Donald Producer: 20060104 In: The Journal of allergy and clinical immunology vol. 116 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	A comparison of once-daily triamcinolone acetonide aqueous and twice-daily beclomethasone dipropionate aqueous nasal sprays in the treatment of seasonal allergic rhinitis. [electronic resource] by Lumry, William Hampel, Frank LaForce, Craig Kiechel, Frederic el-Akkad, Tarek Murray, John J Producer: 20031105 In: Allergy and asthma proceedings vol. 24 Availability: No items available. Save to lists Add to cart (remove)
	16.	The safety of twice-daily treatment with fluticasone propionate and salmeterol in pediatric patients with persistent asthma. [electronic resource] by Malone, Randolph LaForce, Craig Nimmagadda, Sai Schoaf, Lynne House, Karen Ellsworth, Anna Dorinsky, Paul Producer: 20050907 In: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 95 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	17.	Bronchodilator efficacy of indacaterol, a novel once-daily beta2-agonist, in patients with persistent asthma. [electronic resource] by Pearlman, David S Greos, Leon LaForce, Craig Orevillo, Chadwick J Owen, Roger Higgins, Mark Producer: 20080827 In: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology vol. 101 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	18.	Two-week comparison study of olopatadine hydrochloride nasal spray 0.6% versus azelastine hydrochloride nasal spray 0.1% in patients with vasomotor rhinitis. [electronic resource] by Lieberman, Phil Meltzer, Eli O LaForce, Craig F Darter, Amy L Tort, Maria J Producer: 20110930 In: Allergy and asthma proceedings vol. 32 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	19.	The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies. [electronic resource] by Feldman, Gregory J Bernstein, Jonathan A Hamilton, Alan Nivens, Michael C Korducki, Lawrence LaForce, Craig Producer: 20140904 In: SpringerPlus vol. 3 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	20.	Patient satisfaction with a pressurized metered-dose inhaler with an integrated dose counter containing a fixed-dose mometasone furoate/formoterol combination. [electronic resource] by LaForce, Craig Weinstein, Cindy Nathan, Robert A Weinstein, Steven F Staudinger, Heribert Meltzer, Eli O Producer: 20110915 In: The Journal of asthma : official journal of the Association for the Care of Asthma vol. 48 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

1
2
3
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 53 results.